Skip to content

Designing and Evaluating the Effectiveness of an Emotional Intelligence-Based Psychoeducational Intervention to Improve Treatment Adherence in Cardiac Patients: A Randomized Clinical Trial (RCT)

Designing and Evaluating the Effectiveness of an Emotional Intelligence-Based Psychoeducational Intervention to Improve Treatment Adherence in Cardiac Patients: A Randomized Clinical Trial (RCT)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220130053882N3
Enrollment
80
Registered
2025-06-20
Start date
2025-07-11
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: cardiac disease. Condition 2: ischemic heart disease. Angina pectoris Chronic ischemic heart disease

Interventions

Intervention 1: Intervention group: In the intervention group, patients will receive a specially designed educational program. The content of this intervention is developed based on the latest scienti

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of heart disease by a physician: Patients diagnosed with class I and II cardiac conditions, including coronary artery disease (CAD), congestive heart failure (CHF), cardiac arrhythmias, or angina pectoris, who do not require surgery or complex interventions. Age: Between 18 and 65 years. Hospitalization time: No more than 24 hours should have passed since admission. Willingness to participate: Patients must express their willingness to participate in the study and sign the informed consent form. Mental alertness: Patients must be fully conscious and capable of answering questions and participating in the sessions. No significant hearing or speech impairments: Patients should be able to comprehend and express concepts related to emotional intelligence and treatment adherence. No severe psychological disorders: Apart from anxiety and depression related to cardiac illness, patients with major psychiatric disorders such as severe anxiety disorders, psychotic disorders, or major depressive disorder that may prevent effective participation will be excluded.

Exclusion criteria

Exclusion criteria: Non-cooperation with the study: Patients who, for any reason (e.g., absence from educational sessions or failure to complete questionnaires), do not cooperate adequately will be excluded. Critical clinical conditions: If a patient develops a critical medical condition or requires urgent medical interventions that make participation impossible, they will be excluded. Changes in primary treatment: Patients requiring cardiac surgeries such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) will be excluded. Progression in disease severity: If the cardiac condition progresses to class III or IV, due to increased severity, the need for more complex treatments, or physical limitations, the patient will be withdrawn from the study.

Design outcomes

Primary

MeasureTime frame
Treatment adherence. Timepoint: Before the intervention, immediately after the intervention, and one month after the intervention. Method of measurement: Ziaei et al.'s Treatment Adherence questionnaire.

Secondary

MeasureTime frame
Emotional intelligence. Timepoint: Before the intervention, immediately after the intervention, and one month after the intervention. Method of measurement: Trait Emotional Intelligence Questionnaire – Short Form (TEIQue-SF).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirreza Jamshidbeigi

Mashhad University of Medical Sciences

amir.h.r.j@gmail.com+98 918 846 0124

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026